Research ArticleBRAIN
Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment
A.M. Fjell, K.B. Walhovd, I. Amlien, A. Bjørnerud, I. Reinvang, L. Gjerstad, T. Cappelen, F. Willoch, P. Due-Tønnessen, R. Grambaite, A. Skinningsrud, V. Stenset and T. Fladby
American Journal of Neuroradiology June 2008, 29 (6) 1183-1189; DOI: https://doi.org/10.3174/ajnr.A1059
A.M. Fjell
K.B. Walhovd
I. Amlien
A. Bjørnerud
I. Reinvang
L. Gjerstad
T. Cappelen
F. Willoch
P. Due-Tønnessen
R. Grambaite
A. Skinningsrud
V. Stenset
References
- ↵Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–42
- ↵Bell-McGinty S, Lopez OL, Meltzer CC, et al. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005;62:1393–97
- Karas GB, Scheltens P, Rombouts SA, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. NeuroImage 2004;23:708–16
- Du AT, Schuff N, Amend D, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;71:441–47
- ↵Singh V, Chertkow H, Lerch JP, et al. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 2006;129:2885–93
- ↵Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimertype pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42:1681–88
- Naslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000;283:1571–77
- ↵Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002;58:1791–800
- ↵Price JL, Morris JC. Tangles and plaques in nondemented aging and preclinical Alzheimer's disease. Ann Neurol 1999;45:358–68
- ↵Wahlund, L-O, Blennow K. Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci Lett 2003;339:99–102
- ↵de Leon MJ, DeSanti S, Zinkowski R, et al. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging 2006;27:394–401
- ↵Hampel H, Burger K, Pruessner JC, et al. Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch Neurol 2005;62:770–73
- ↵Grossman MM, Farmer JJ, Leight SS, et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol 2005;57:721–29
- ↵Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921–23
- ↵Huang Y, Weisgraber KH, Mucke L, et al. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci 2004;23:189–204
- ↵Ye S, Huang Y, Mullendorff K, et al. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A 2005;102:18700–05
- ↵Espeseth T, Westlye LT, Fjell AM, et al. Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol Aging 2008;29:329–40
- ↵Deweer B, Lehericy S, Pillon B, et al. Memory performance in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry 1995;58:590–97
- Heun R, Mazanek M, Atzor KR, et al. Amygdala hippocampal atrophy and memory performance in dementia of Alzheimer type. Dement Geriatr Cogn Disord 1997;8:329–36
- Mori E, Yoneda Y, Yamashita H, et al. Medial temporal structures related to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry 1997;63:214–21
- ↵Small SA, Perera GM, DeLaPaz R, et al. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 1999;45:466–72
- ↵Buckner RL. Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 2004;44:195–208
- ↵Buckner RL, Wheeler ME. The cognitive neuroscience of remembering. Nat Rev Neurosci 2001;2:624–34
- ↵Walhovd KB, Fjell AM, Dale AM, et al. Regional cortical thickness matters in recall after months more than minutes. Neuroimage 2006;31:1343–51
- ↵Guillozet AL, Weintraub S, Mash DC, et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003;60:729–36
- ↵Ivanoiu A, Sindic C. Cerebrospinal fluid TAU protein and amyloid beta42 in mild cognitive impairment: prediction of progression to Alzheimer's disease and correlation with the neuropsychological examination. Neurocase 2005;11:32–39
- ↵Schoonenboom SN, Visser PJ, Mulder C, et al. Biomarker profiles and their relation to clinical variables in mild cognitive impairment. Neurocase 2005;11:8–13
- ↵Andersson C, Blennow K, Johansson SE, et al. Differential CSF biomarker levels in APOE-epsilon 4-positive and -negative patients with memory impairment. Dement Geriatr Cogn Disord 2007;23:87–95
- ↵Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262–70
- ↵Reisberg B, Ferris SH, de Leon MJ, et al. Global Deterioration Scale (GDS). Psychopharmacol Bull 1988;24:661–63
- ↵
- ↵Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatr Res 1975;12:189–98
- ↵Sjögren M, Vanderstichele H, Agren H, et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21–91 years of age; establishment of reference values. Clin Chem 2001;47:1776–81
- ↵Dale AM, Sereno MI. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J Cogn Neurosci 1993;5:162–76
- Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 1999;9:179–94
- Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. NeuroImage 1999;9:195–207
- Fischl B, Sereno MI, Tootell RB, et al. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999;8:272–84
- Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 2001;20:70–80
- Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000;97:11050–55
- ↵Salat DH, Buckner RL, Snyder AZ, et al. Thinning of the cerebral cortex in aging. Cereb Cortex 2004;14:721–30
- ↵Rosas HD, Liu AK, Hersch S, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002;58:695–701
- ↵Kuperberg GR, Broome MR, McGuire PK, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003;60:878–88
- ↵Fischl B, Salat DH, Busa E, et al. Whole brain segmentation. Automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55
- ↵Makris N, Meyer J, Bates J, et al. MRI-based parcellation of human cerebral white matter and nuclei. Part II. Rationale and applications with systematics of cerebral connectivity. NeuroImage 1999;9:18–45
- ↵Corwin J, Bylsma FW. Translations of excerpts from the Andre Rey's psychological examination of traumatic encephalopathy and P.A. Osterreith's the complex figure copy test. Clin Neuropsychol 1993;7:3–15
- Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France;1964
- ↵Lezak MD. Neuropsychological assessment, 3rd ed. Oxford: Oxford University Press;1995
- ↵de Leon MJ, George AE, Stylopoulos LA, et al. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet 1989;2:672–73
- ↵Mesulam MM. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999;24:521–29
- ↵Rowe CC, Ng S, Ackermann U, et al. Imaging β-amyloid burden in aging and dementia. Neurology 2007;68:1718–25
- ↵Edison P, Archer HA, Hinz R, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 2007;68:501–08
- ↵Weniger G, Boucsein K, Irle E. Impaired associative memory in temporal lobe epilepsy subjects after lesions of hippocampus, parahippocampal gyrus, and amygdala. Hippocampus 2004;14:785–96
- ↵Han X, Jovicich J, Salat D, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006;32:180–94
- ↵Dickerson BC, Fenstermacher E, Salat DH, et al. Detection of cortical thickness correlates of cognitive performance: reliability across MRI scan sessions, scanners, and field strength. Neuroimage 2008;39:10–18
In this issue
Advertisement
Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment
A.M. Fjell, K.B. Walhovd, I. Amlien, A. Bjørnerud, I. Reinvang, L. Gjerstad, T. Cappelen, F. Willoch, P. Due-Tønnessen, R. Grambaite, A. Skinningsrud, V. Stenset, T. Fladby
American Journal of Neuroradiology Jun 2008, 29 (6) 1183-1189; DOI: 10.3174/ajnr.A1059
Morphometric Changes in the Episodic Memory Network and Tau Pathologic Features Correlate with Memory Performance in Patients with Mild Cognitive Impairment
A.M. Fjell, K.B. Walhovd, I. Amlien, A. Bjørnerud, I. Reinvang, L. Gjerstad, T. Cappelen, F. Willoch, P. Due-Tønnessen, R. Grambaite, A. Skinningsrud, V. Stenset, T. Fladby
American Journal of Neuroradiology Jun 2008, 29 (6) 1183-1189; DOI: 10.3174/ajnr.A1059
Jump to section
Related Articles
- No related articles found.
Cited By...
- White matter integrity and cognition in Parkinson's disease: a cross-sectional study
- Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease
- CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
- Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
- One-Year Brain Atrophy Evident in Healthy Aging
- Minute Effects of Sex on the Aging Brain: A Multisample Magnetic Resonance Imaging Study of Healthy Aging and Alzheimer's Disease
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Anders M. Fjell, Kristine B. WalhovdReviews in the Neurosciences 2010 21 3
- Anders M. Fjell, Kristine B. Walhovd, Christine Fennema-Notestine, Linda K. McEvoy, Donald J. Hagler, Dominic Holland, James B. Brewer, Anders M. DaleThe Journal of Neuroscience 2009 29 48
- N. Schuff, N. Woerner, L. Boreta, T. Kornfield, L. M. Shaw, J. Q. Trojanowski, P. M. Thompson, C. R. Jack, M. W. WeinerBrain 2008 132 4
- Paul K. Crane, Adam Carle, Laura E. Gibbons, Philip Insel, R. Scott Mackin, Alden Gross, Richard N. Jones, Shubhabrata Mukherjee, S. McKay Curtis, Danielle Harvey, Michael Weiner, Dan MungasBrain Imaging and Behavior 2012 6 4
- K.B. Walhovd, A.M. Fjell, J. Brewer, L.K. McEvoy, C. Fennema-Notestine, D.J. Hagler, R.G. Jennings, D. Karow, A.M. DaleAmerican Journal of Neuroradiology 2010 31 2
- Anders M. Fjell, Kristine B. Walhovd, Christine Fennema-Notestine, Linda K. McEvoy, Donald J. Hagler, Dominic Holland, James B. Brewer, Anders M. DaleThe Journal of Neuroscience 2010 30 6
- M. Wagner, S. Wolf, F.M. Reischies, M. Daerr, S. Wolfsgruber, F. Jessen, J. Popp, W. Maier, M. Hüll, L. Frölich, H. Hampel, R. Perneczky, O. Peters, H. Jahn, C. Luckhaus, H.-J. Gertz, J. Schröder, J. Pantel, P. Lewczuk, J. Kornhuber, J. WiltfangNeurology 2012 78 6
- Geraldo F Busatto, Breno S Diniz, Marcus V ZanettiExpert Review of Neurotherapeutics 2008 8 11
- Lars T. Westlye, Kristine B. Walhovd, Anders M. Dale, Thomas Espeseth, Ivar Reinvang, Naftali Raz, Ingrid Agartz, Douglas N. Greve, Bruce Fischl, Anders M. FjellNeuroImage 2009 47 4
- Duygu Tosun, Norbert Schuff, Diana Truran-Sacrey, Leslie M. Shaw, John Q. Trojanowski, Paul Aisen, Ronald Peterson, Michael W. WeinerNeurobiology of Aging 2010 31 8
More in this TOC Section
Similar Articles
Advertisement